Authors:
LOEBSTEIN R
DALAL I
NISBETBROWN E
BERKOVITCH M
MEYDAN N
ANDREWS D
LOUBSER MD
KOREN G
ROIFMAN CM
OLIVIERI NF
Citation: R. Loebstein et al., IMMUNE FUNCTION IN PATIENTS WITH BETA-THALASSEMIA RECEIVING THE ORALLY-ACTIVE IRON-CHELATING AGENT DEFERIPRONE, British Journal of Haematology, 98(3), 1997, pp. 597-600